DCAL

DISHMAN CARBOGEN AMCIS

Small Cap BSE: 540701 NSE: DCAL
₹94.85
1.25 (1.34%)
As on 30 September, 2022 | 02:02

Dishman Carbogen Amcis Share Price

Dishman Carbogen Amcis Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in DISHMAN CARBOGEN AMCIS

Start SIP

Dishman Carbogen Amcis Share Returns

  • Over 1 Month -18.65%
  • Over 3 Month -18.37%
  • Over 6 Month -48.55%
  • Over 1 Year -52.13%

Dishman Carbogen Amcis Key Statistics

P/E Ratio 249.5
PEG Ratio 2.4
Market Cap Cr 1,487
Price to Book Ratio 0.3
EPS -1.6
Dividend 0
Relative Strength Index 25.74
Money Flow Index 33.25
MACD Signal -5.27
Average True Range 4.83

Dishman Carbogen Amcis Investment Rating

  • Master Rating:
  • Dishman Carbogen Amcis has an operating revenue of Rs. 2,130.58 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 14 which is a POOR score indicating inconsistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Dishman Carbogen Amcis Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 1048373846487
Operating Expenses Qtr Cr 1018269596077
Operating Profit Qtr Cr 31425410
Depreciation Qtr Cr 353435363535
Interest Qtr Cr 1310118810
Tax Qtr Cr -15-38-6-2-7112
Net Profit Qtr Cr -255-20-3-14-142

Dishman Carbogen Amcis Technicals

EMA & SMA

Current Price
94.85
1.25 (1.34%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 104.15
  • 50 Day
  • 112.56
  • 100 Day
  • 124.51
  • 200 Day
  • 153.06
  • 20 Day
  • 106.82
  • 50 Day
  • 115.52
  • 100 Day
  • 117.09
  • 200 Day
  • 152.93

Dishman Carbogen Amcis Resistance and Support

PIVOT
₹93.2
Resistance
First Resistance 95.5
Second Resistance 97.4
Third Resistance 99.7
RSI 25.74
MFI 33.25
MACD Single Line -5.27
MACD -6.52
Support
First Resistance 91.3
Second Resistance 89
Third Resistance 87.1

Dishman Carbogen Amcis Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 502,473 19,576,348 38.96
Week 756,096 37,078,967 49.04
1 Month 605,539 31,942,202 52.75
6 Month 413,732 16,793,392 40.59

Dishman Carbogen Amcis Result Highlights

Dishman Carbogen Amcis Synopsis

NSE-Medical-Diversified

Dishman Carbogen Amc is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 302.79 Cr. and Equity Capital is Rs. 31.36 Cr. for the Year ended 31/03/2022. Dishman Carbogen Amcis Ltd. is a Public Limited Listed company incorporated on 17/07/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L74900GJ2007PLC051338 and registration number is 051338.
Market Cap 1,487
Sales 344
Shares in Float 6.43
No of funds 49
Yield
Book Value 0.35
U/D Vol ratio 0.6
LTDebt / Equity 3
Alpha -0.24
Beta 1.49

Dishman Carbogen Amcis

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 59.32%59.32%59.32%
Mutual Funds 6.54%6.75%6.18%
Insurance Companies
Foreign Portfolio Investors 5.85%5.5%4.6%
Individual Investors 23.72%23.55%24.2%
Others 4.57%4.88%5.7%

Dishman Carbogen Amcis Management

Name Designation
Mr. Janmejay R Vyas Chairman
Mr. Arpit J Vyas Group Managing Director
Mrs. Deohooti J Vyas Whole Time Director
Mr. Sanjay S Majmudar Independent Director
Mr. Ashok C Gandhi Independent Director
Mr. Rajendra S Shah Independent Director
Mr. Subir Kumar Das Independent Director
Mr. Mark C Griffiths Independent Director
Mr. Maitri K Mehta Director

Dishman Carbogen Amcis Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Dishman Carbogen Amcis Corporate Action

Date Purpose Remarks
2022-08-09 Quarterly Results
2022-05-10 Audited Results
2022-02-03 Quarterly Results
2021-10-28 Quarterly Results
2021-08-12 Quarterly Results

Dishman Carbogen Amcis MF Shareholding

Name Amount(cr)
Aditya Birla Sun Life Flexi Cap Fund Growth 16103
Aditya Birla Sun Life Pure Value Fund Growth 4047
L&T Flexicap Fund Growth 2885
Quant Active Fund Growth 2857
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 2465

Dishman Carbogen Amcis FAQs

What is Share Price of Dishman Carbogen Amcis ?

Dishman Carbogen Amcis share price is ₹94 As on 30 September, 2022 | 01:48

What is the Market Cap of Dishman Carbogen Amcis ?

The Market Cap of Dishman Carbogen Amcis is ₹1487.1 Cr As on 30 September, 2022 | 01:48

What is the P/E ratio of Dishman Carbogen Amcis ?

The P/E ratio of Dishman Carbogen Amcis is 249.5 As on 30 September, 2022 | 01:48

What is the PB ratio of Dishman Carbogen Amcis ?

The PB ratio of Dishman Carbogen Amcis is 0.3 As on 30 September, 2022 | 01:48

Q1FY23